Clinical Trials Directory

Trials / Completed

CompletedNCT02996097

Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effects of fractional carbon dioxide (CO2) laser therapy immediately followed by intralesional steroid therapy against intralesional steroid therapy alone for the treatment of keloids.

Detailed description

Intralesional corticosteroids remain the gold standard treatment for keloids. However, more effective therapies are desperately desired. Ablative fractional laser (AFL) treatment facilitates delivery of intralesional steroid more deeply and uniformly into the skin by creating vertical channels. Recent studies have showed that fractional laser assisted steroid therapy can be effective in the treatment of keloids. However the studies are lacking in comparing this treatment modality to the gold standard of intralesional steroids.

Conditions

Interventions

TypeNameDescription
DEVICEThe Lutronic electronic carbon dioxide (eCO2) Plus laser systemCO2 ablative laser plus intralesional triamcinolone acetonide A topical EMLA cream or tetracaine 7%/lidocaine 23% will be applied to the both treatment sites and after sufficient anesthesia is attained, one keloid will be treated with the fractional CO2 laser using standard protocol as practiced in our clinics followed by intralesional triamcinolone acetonide. One lesion would be treated with fractional CO2 ablative laser followed with intralesional triamcinolone acetonide at 4 weeks intervals
DRUGIntralesional Triamcinolone Acetonide

Timeline

Start date
2016-04-01
Primary completion
2018-06-15
Completion
2018-06-15
First posted
2016-12-19
Last updated
2020-12-17
Results posted
2019-04-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02996097. Inclusion in this directory is not an endorsement.